Durvalumab +/- tremelimumab plus platinum-etoposide in first-line extensive-stage SCLC (ES-SCLC): Updated results from the phase III CASPIAN study.

Paz-Ares, Luis G.; Dvorkin, Mikhail; Chen, Yuanbin; Reinmuth, Niels; Hotta, Katsuyuki; Trukhin, Dmytro; Statsenko, Galina; Hochmair, Maximilian; Ozguroglu, Mustafa; Ji, Jun Ho; Voitko, Oleksandr; Poltoratskiy, Artem; Verderame, Francesco; Havel, Libor; Bondarenko, Igor; Armstrong, Jon; Byrne, Natalie; Jiang, Haiyi; Goldman, Jonathan Wade

dc.contributor.author	Paz-Ares, Luis G.
dc.contributor.author	Dvorkin, Mikhail
dc.contributor.author	Chen, Yuanbin
dc.contributor.author	Reinmuth, Niels
dc.contributor.author	Hotta, Katsuyuki
dc.contributor.author	Trukhin, Dmytro
dc.contributor.author	Statsenko, Galina
dc.contributor.author	Hochmair, Maximilian
dc.contributor.author	Ozguroglu, Mustafa
dc.contributor.author	Ji, Jun Ho
dc.contributor.author	Voitko, Oleksandr
dc.contributor.author	Poltoratskiy, Artem
dc.contributor.author	Verderame, Francesco
dc.contributor.author	Havel, Libor
dc.contributor.author	Bondarenko, Igor
dc.contributor.author	Armstrong, Jon
dc.contributor.author	Byrne, Natalie
dc.contributor.author	Jiang, Haiyi
dc.contributor.author	Goldman, Jonathan Wade
dc.date.accessioned	2021-03-02T18:34:57Z
dc.date.available	2021-03-02T18:34:57Z
dc.date.issued	2020
dc.identifier.citation	Paz-Ares L. G. , Dvorkin M., Chen Y., Reinmuth N., Hotta K., Trukhin D., Statsenko G., Hochmair M., Ozguroglu M., Ji J. H. , et al., "Durvalumab +/- tremelimumab plus platinum-etoposide in first-line extensive-stage SCLC (ES-SCLC): Updated results from the phase III CASPIAN study.", JOURNAL OF CLINICAL ONCOLOGY, cilt.38, sa.15, 2020
dc.identifier.issn	0732-183X
dc.identifier.other	vv_1032021
dc.identifier.other	av_46fcd501-e680-49ba-b6ff-be7d04f04fab
dc.identifier.uri	http://hdl.handle.net/20.500.12627/5219
dc.language.iso	eng
dc.subject	Klinik Tıp (MED)
dc.subject	ONKOLOJİ
dc.subject	Klinik Tıp
dc.subject	Sağlık Bilimleri
dc.subject	Dahili Tıp Bilimleri
dc.subject	İç Hastalıkları
dc.subject	Onkoloji
dc.subject	Tıp
dc.title	Durvalumab +/- tremelimumab plus platinum-etoposide in first-line extensive-stage SCLC (ES-SCLC): Updated results from the phase III CASPIAN study.
dc.type	Makale
dc.relation.journal	JOURNAL OF CLINICAL ONCOLOGY
dc.contributor.department	, ,
dc.identifier.volume	38
dc.identifier.issue	15
dc.contributor.firstauthorID	2281621

Bu öğenin dosyaları:

Dosyalar	Boyut	Biçim	Göster
Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Makale [92796]

Basit öğe kaydını göster